key: cord-0877308-qavm398m
authors: Wang, Guoying; Cai, Linghao; Chen, Dandan; Teng, Tieshan; Li, Qiming; Xie, Longxiang
title: Influence of COVID‐19 in patients with concurrent tuberculosis coinfections
date: 2021-01-26
journal: J Med Virol
DOI: 10.1002/jmv.26801
sha: 4d70a0885fd5a1dfc40bc1c384988f45807d2e5a
doc_id: 877308
cord_uid: qavm398m

nan

To the Editor, With great interest, we read the recent review and meta-analyses written by Sarkar et al., 1 which systematically assessed the consequence of COVID-19 in patients with concurrent infections, including tuberculosis (TB), influenza, HIV, chronic hepatitis, and dengue. The authors concluded that TB patients show an increased risk of mortality during coinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while there is no significant impact found in patients living with HIV and chronic hepatitis. Although we appreciate the authors who performed comprehensive data analysis, we believe that further discussion on these findings is warranted.

First, the authors limited their search to PubMed, Medline, Embase, Google Scholar, and MedRxiv, but did not explore other international databases with broad subject areas, including Cochrane Library, ClinicalTrials.gov, and other large preprint platforms such as bioRxiv. The selection of a restricted subset of databases for performing the literature search may cause biased results. 2 Second, in the meta-analysis study about the influence of TB on mortality in COVID-19 patients, we think Chen et al.'s 3 study cannot be included in the pooled result because the number of death event (n = 1) in the TB group is not accurate and should be more. After carefully checking the original information, we found that among COVID-19 patients (age ≥ 65 years) with concurrent TB coinfections, there was only one death event, but for patients (age < 65 years) with concurrent TB coinfections, the detailed death events were not shown.

Hence, this study cannot be incorporated into the meta-analyses.

In addition, we found an error in the data of Fig. 3 Finally, studies had shown that the older COVID-19 patients have greater initial comorbidities, more severe symptoms, and higher mortality rate as compared with younger patients. 3, 7 Thus, the age should be taken into consideration to draw a firm conclusion. Therefore, it will better to perform a subgroup analysis in However, extensive sample studies are still needed to further verify the results mentioned.

Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses

2 Meta-analysis of the impact of virus infection, including HIV, chronic hepatitis, and influenza on mortality in COVID-19 patients

Cochrane Handbook For Systematic Reviews of Interventions Version 5.1.0. (The Cochrane Collaboration

Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study

HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19

COVID-19 response team severe outcomes among patients with coronavirus disease 2019 (COVID-19)-United States